Anand Gaurav

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 5

Top Topics

Benign Prostatic Hyperplasia

Lower Urinary Tract Symptoms

Signaling Pathway

Top Venues

Molecular diversity

Advances in urology

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Mayasah Al-Nema, Anand Gaurav, Ming Tatt Lee, Patrick Okechukwu, Piyarat Nimmanpipug, Vannajan Sanghiran Lee
Evaluation of the acute oral toxicity and antipsychotic activity of a dual inhibitor of PDE1B and PDE10A in rat model of schizophrenia. PloS one 17 (12) (2022)
Fatemeh Akbari, Mohammad Azadbakht, Anand Gaurav, Fatemeh Azimi, Zahra Mahdizadeh, Laleh Vahedi Larijani, Ayob Barzegar Nejad, Aroona Chabra, Mohammad Eghbali
Evaluation of the Therapeutic Effect of the Traditional Herbal Medicine Atrifil and Oshagh Gum on Testosterone-Induced Benign Prostatic Hyperplasia in Wistar Rats. Advances in urology 2022 (2022)
Vertika Gautam, Anand Gaurav, Neeraj Masand, Vannajan Sanghiran Lee, Vaishali M Patil
Artificial intelligence and machine-learning approaches in structure and ligand-based discovery of drugs affecting central nervous system. Molecular diversity (2022)
Mayasah Al-Nema, Anand Gaurav, Vannajan Sanghiran Lee, Baskaran Gunasekaran, Ming Tatt Lee, Patrick Okechukwu, Piyarat Nimmanpipug
Structure-based discovery and bio-evaluation of a cyclopenta[4,5]thieno[2,3- d ]pyrimidin-4-one as a phosphodiesterase 10A inhibitor. RSC advances 12 (3) (2022)
Okechukwu Patrick Nwabueze, Mridula Sharma, Abbirami Balachandran, Anand Gaurav, Anis Najwa Abdul Rani, Małgorzata Jeleń, Morak-Młodawska Beata, Charlie A Lavilla, Merell P Billacura
Comparative Studies of Palmatine with Metformin and Glimepiride on the Modulation of Insulin Dependent Signaling Pathway In Vitro, In Vivo & Ex Vivo. Pharmaceuticals (Basel, Switzerland) 15 (11) (2022)